Assessment of neurotoxicity of gadolinium nanocomposite
- Autores: Novikov M.A.1, Titov E.A.1, Yakimova N.L.1, Vokina V.A.1, Pankova A.A.1, Skrynnik A.S.1, Lizarev A.V.1, Sosedova L.M.1
-
Afiliações:
- East Siberian Institute of Medical and Ecological Research
- Edição: Volume 103, Nº 11 (2024)
- Páginas: 1423-1428
- Seção: PREVENTIVE TOXICOLOGY AND HYGIENIC STANDARTIZATION
- ##submission.datePublished##: 15.12.2024
- URL: https://archivog.com/0016-9900/article/view/646127
- DOI: https://doi.org/10.47470/0016-9900-2024-103-11-1423-1428
- EDN: https://elibrary.ru/ozbxtk
- ID: 646127
Citar
Resumo
Introduction. A promising area of nanotoxicology is the study of the effects of gadolinium nanoparticles on a living organism, which will allow achieving high image contrast when performing MRI with a significantly smaller amount of the injected substance. This is possible using high-molecular compounds, for example, arabinogalactan of Siberian larch, which has a stabilizing effect for nanoparticles.
Materials and methods. Experimental studies were performed on ninety six mongrel white male rats weighing 180–240 g, divided into 3 groups (one control and two experimental). A water-based solution was used as the exposed substance, which included gadolinium nanoparticles, as well as a nanostabilizing matrix – the natural polysaccharide arabinogalactan. The solution was administered orally for 10 days in two doses – 500 and 5000 mcg of gadolinium per 1 kg of animal body weight. After the introduction, some of the animals were withdrawn from the experiment and made up the early examination period, the remaining part of the animals were left to survive for 6 months and made up the long-term examination period, and subsequently were also withdrawn from the experiment. The work used a set of studies aimed at determining neurotoxicity – the “Open Field” test, EEG examination, morphological and morphometric methods.
Results. The structural and functional features of the effect of gadolinium nanocomposite on the central nervous system were expressed in an increase in the number of degeneratively altered neurons when administered a solution at a dose of 500 mcg of gadolinium per 1 kg of animal body weight in the early period of examination, while indices reflecting approximate research activity, behaviour and EEG indices, compared with the control, did not changed.
Limitations. When studying the effects of gadolinium nanoparticles encapsulated in the polysaccharide arabinogalactan on 96 outbred male rats, which is sufficient to use a set of methods to determine the functional state of the central nervous system and structural changes in nervous tissue.
Conclusion. Thus, the subacute effect of gadolinium nanoparticles encapsulated in the arabinogalactan matrix causes structural changes in the nervous tissue, while functional changes in the central nervous system were not observed.
Compliance with ethical standards. The work was carried out in accordance with the protocol of experimental studies, the principles set out in the European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes ETS No. 123, GOST 33215–2014 “Guide to the care and maintenance of laboratory animals. Rules for equipping premises and organizing procedures», Recommendations for euthanasia of experimental animals: Part 1, Part 2. Permission to conduct the research was obtained from the Local Ethics Committee (protocol No. 8 dated 15.12.2023).
Contribution:
Novikov M.A., Sosedova L.M. — study concept and design, writing text, editing;
Titov E.A., Vokina V.A. — study concept and design, editing;
Yakimova N.L., Pankova A.A., Skrynnik A.S., Lizarev A.V. — data collection and data processing.
All authors are responsible for the integrity of all parts of the manuscript and approval of the manuscript final version.
Conflict of interest. The authors declare no conflict of interest.
Acknowledgement. The study was carried out within the framework of the state assignment of the East Siberian Institute of Medical and Ecological Research.
Received: July 8, 2024 / Revised: October 15, 2024 / Accepted: November 19, 2024 / Published: December 17, 2024
Palavras-chave
Sobre autores
Mikhail Novikov
East Siberian Institute of Medical and Ecological Research
Email: novik-imt@mail.ru
PhD (Biology), Senior Researcher, Laboratory of Biomodelling and Translational Medicine, East-Siberian Institute of Medical and Ecological Research, Angarsk, 665826, Russian Federation
e-mail: novik-imt@mail.ru
Evgeny Titov
East Siberian Institute of Medical and Ecological Research
Email: g57097@yandex.ru
PhD (Biology), Senior Researcher, Laboratory of Biomodelling and Translational Medicine, East-Siberian Institute of Medical and Ecological Research, Angarsk, 665826, Russian Federation
e-mail: g57097@yandex.ru
Natalia Yakimova
East Siberian Institute of Medical and Ecological Research
Email: ynl-77@list.ru
PhD (Biology), Senior Researcher, Laboratory of Biomodelling and Translational Medicine, East-Siberian Institute of Medical and Ecological Research, Angarsk, 665826, Russian Federation
e-mail: ynl-77@list.ru
Vera Vokina
East Siberian Institute of Medical and Ecological Research
Email: vokina.vera@gmail.com
PhD (Biology), Senior Researcher, Laboratory of Biomodelling and Translational Medicine, East-Siberian Institute of Medical and Ecological Research, Angarsk, 665826, Russian Federation
e-mail: vokina.vera@gmail.com
Anna Pankova
East Siberian Institute of Medical and Ecological Research
Email: nyuta.pankova.96@mail.ru
Junior Researcher, Laboratory of Biomodelling and Translational Medicine, East-Siberian Institute of Medical and Ecological Research, Angarsk, 665826, Russian Federation
e-mail: nyuta.pankova.96@mail.ru
Anna Skrynnik
East Siberian Institute of Medical and Ecological Research
Email: annaskrynnik675@gmail.com
Junior Researcher, Laboratory of Biomodelling and Translational Medicine, East-Siberian Institute of Medical and Ecological Research, Angarsk, 665826, Russian Federation
e-mail: annaskrynnik675@gmail.com
Aleksander Lizarev
East Siberian Institute of Medical and Ecological Research
Email: lis_lu154@mail.ru
Junior Researcher, Laboratory of Biomodelling and Translational Medicine, East-Siberian Institute of Medical and Ecological Research, Angarsk, 665826, Russian Federation
e-mail: lis_lu154@mail.ru
Larisa Sosedova
East Siberian Institute of Medical and Ecological Research
Autor responsável pela correspondência
Email: sosedlar@mail.ru
DSc (Medicine), Professor, Head of Laboratory of Biomodelling and Translational Medicine, East-Siberian Institute of Medical and Ecological Research, Angarsk, 665826, Russian Federation
e-mail: sosedlar@mail.ru
Bibliografia
- Hui F.K., Mullins M. Persistence of gadolinium contrast enhancement in CSF: a possible harbinger of gadolinium neurotoxicity? AJNR Am. J. Neuroradiol. 2009; 30(1): E1. https://doi.org/10.3174/ajnr.A1205
- Lersy F., Boulouis G., Clément O., Desal H., Anxionnat R., Berge J., et al. Consensus guidelines of the French society of neuroradiology (SFNR) on the use of Gadolinium-based contrast agents (GBCAs) and related MRI protocols in neuroradiology. J. Neuroradiol. 2020; 47(6): 441–9. https://doi.org/10.1016/j.neurad.2020.05.008
- Blasco-Perrin H., Glaser B., Pienkowski M., Peron J.M., Payen J.L. Gadolinium induced recurrent acute pancreatitis. Pancreatology. 2013; 13(1): 88–9. https://doi.org/10.1016/j.pan.2012.12.002
- Akgun H., Gonlusen G., Cartwright J. Jr., Suki W.N., Truong L.D. Are gadolinium-based contrast media nephrotoxic? A renal biopsy study. Arch. Pathol. Lab. Med. 2006; 130(9): 1354–7. https://doi.org/10.5858/2006-130-1354-AGCMNA
- Lesnichaya M.V., Aleksandrova G.P., Feoktistova L.P., Sapozhnikov A.N., Fadeeva T.V., Sukhov B.G., et al. Silver-containing nanocomposites based on galactomannan and carrageenan: synthesis, structure, and antimicrobial properties. Russ. Chem. Bull. 2010; 59: 2323–8. https://doi.org/10.1007/s11172-010-0395-6
- Novikov M.A., Titov E.A., Sosedova L.M., Rukavishnikov V.S., Vokina V.A., Lakhman O.L. Comparative assessment of silver nanocomposites’ biological effects on the natural and synthetic matrix. Int. J. Mol. Sci. 2021; 22(24): 13257. https://doi.org/10.3390/ijms222413257
- Babkin V.A. Theoretical and practical development of new drugs for medicine based on larch biomass extracts. Russ. J. Bioorg. Chem. 2015; 41: 679–85. https://doi.org/10.1134/S1068162015070031
- Sukhov B.G., Trofimov B.A. Directed synthesis of nanocomposites with an unusual complex of magnetic, optical, catalytic and biologically active properties. In: Magnetic Materials. New Technologies. Abstracts of the VIII Baikal International Conference [Magnitnye materialy. Novye tekhnologii. Tezisy dokladov VIII Baikal’skoi mezhdunarodnoi konferentsii]. Irkutsk; 2018. https://elibrary.ru/xvwuep (in Russian)
- Rukavishnikov V.S., Novikov M.A., Titov E.A., Sosedova L.M., Vokina V.A., Yakimova N.L. Estimation of toxic properties of nanocomposites containing nanoparticles of bismuth, gadolinium, and silver. Trace Elem. Electroly. 2018; 35(4): 203–6. https://doi.org/10.5414/TEX0155408 https://elibrary.ru/yokibn
- Kulikov A.V., Tikhonova M.A., Kulikov V.A. Automated measurement of spatial preference in the open field test with transmitted lighting. J. Neurosci. Methods. 2008; 170(2): 345–51. https://doi.org/10.1016/j.jneumeth.2008.01.024
- Gulani V., Calamante F., Shellock F.G., Kanal E., Reeder S.B. Gadolinium deposition in the brain: summary of evidence and recommendations. Lancet Neurol. 2017; 16(7): 564–70. https://doi.org/10.1016/S1474-4422(17)30158-8
- Rogosnitzky M., Branch S. Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms. Biometals. 2016; 29: 365–76. https://doi.org/10.1007/s10534-016-9931-7
- Sosedova L.M., Titov E.A., Novikov M.A., Vokina V.A., Rukavishnikov V.S. Evaluation of toxic effects of magnetic contrast diagnostic gadolinium-containing nanocomposite. Gigiena i Sanitaria (Hygiene and Sanitation, Russian journal). 2019; 98(10): 1161–5. https://elibrary.ru/suzsns (in Russian)
- Akai H., Miyagawa K., Takahashi K., Mochida-Saito A., Kurokawa K., Takeda H., et al. Effects of gadolinium deposition in the brain on motor or behavioral function: a mouse model. Radiology. 2021; 301(2): 409–16. https://doi.org/10.1148/radiol.2021210892
- Ayers-Ringler J., McDonald J.S., Connors M.A., Fisher C.R., Han S., Jakaitis D.R., et al. Neurologic effects of gadolinium retention in the brain after gadolinium-based contrast agent administration. Radiology. 2022; 302(3): 676–83. https://doi.org/10.1148/radiol.210559
- Titov E.A., Sosedova L.M., Kapustina E.A., Yakimova N.L., Novikov M.A., Lisetskaya L.G., et al. Analysis of the toxicity of a Cu2O nanocomposite encapsulated in a polymer matrix of arabinogalactan. Rossiiskie nanotekhnologii. 2021; 16(4): 578–84. https://doi.org/10.1134/S1992722321040130 https://elibrary.ru/ubziho (in Russian)
Arquivos suplementares
